Effectiveness and safety of oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate recurrence risk

Author:

Johnsen Søren P.12ORCID,Rasmussen Thomas B.1,Falstie‐Jensen Anne Mette1,Harboe Louise3,Stynes Gillian4,Dybro Lars5,Hansen Morten L.6,Brandes Axel7,Grove Erik L.89,Münster Anna‐Marie10

Affiliation:

1. Department of Clinical Epidemiology Aarhus University Hospital Aarhus Denmark

2. Danish Center for Clinical Health Services Research, Department of Clinical Medicine Aalborg University Aalborg Denmark

3. Bristol Myers Squibb Copenhagen Denmark

4. Worldwide Value, Access and Pricing & HEOR Bristol Myers Squibb Lawrenceville New Jersey USA

5. Internal medicine, Pfizer Pharmaceutical Group Pfizer Copenhagen Denmark

6. Department of Cardiology Gentofte Hospital Copenhagen Denmark

7. Department of Cardiology Odense University Hospital Odense Denmark

8. Department of Cardiology Aarhus University Hospital Aarhus Denmark

9. Department of Clinical Medicine, Faculty of Health Aarhus University Aarhus Denmark

10. Unit for Thrombosis Research, Esbjerg Hospital of SouthWest Denmark Esbjerg Denmark

Funder

Pfizer

Bristol-Myers Squibb

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3